OSAM
KNSA icon

O'Shaughnessy Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

O'Shaughnessy Asset Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19
Closed – – 1883
2021
Q3 		$0 Hold
19
– – ﹤0.01% 2797
2021
Q2 		$0 Hold
19
– – ﹤0.01% 2641
2021
Q1 		$0 Hold
19
– – ﹤0.01% 2416
2020
Q4 		$0 Hold
19
– – ﹤0.01% 2150
2020
Q3 		$0 Hold
19
– – ﹤0.01% 1932
2020
Q2 		$0 Buy
+19
New +$397 ﹤0.01% 1806
2020
Q1 		– Sell
-19
Closed – – 1557
2019
Q4 		$0 Buy
+19
New +$165 ﹤0.01% 1857

Other funds holding KNSA

PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

O'Shaughnessy Asset Management's KNSA Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Kiniksa Pharmaceuticals (KNSA) in Q4 2021, closing a stake of 19 shares.

O'Shaughnessy Asset Management first reported a position in KNSA in Q4 2019 and held it in 7 quarters. The position peaked at $0 in Q3 2021. 103 funds tracked by Wall St. Rank hold KNSA as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Kiniksa Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 19 Kiniksa Pharmaceuticals shares in Q4 2021.
  • O'Shaughnessy Asset Management first reported a position in Kiniksa Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • O'Shaughnessy Asset Management's Kiniksa Pharmaceuticals position peaked at $0 in Q3 2021.
  • 103 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.